SUMMARY OF COMMON SHARE PURCHASE WARRANT ACTIVITY (Details) - $ / shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Equity [Abstract] | ||
| Outstanding, beginning of the period | 42,526,857 | 6,891,099 |
| Outstanding, weighted average exercise price | $ 1.15 | $ 1.50 |
| Issued | 146,274,510 | 36,281,409 |
| Issued, weighted average exercise price | $ 0.48 | $ 1.10 |
| Exercised | ||
| Exercised, weighted average exercise price | ||
| Expired | (221,448) | (645,651) |
| Expired, weighted average exercise price | $ (1.75) | $ (2.05) |
| Outstanding, end of the period | 188,579,919 | 42,526,857 |
| Outstanding, weighted average exercise price | $ 0.63 | $ 1.15 |
| X | ||||||||||
- Definition Class of warrant or right weighted average Eexercise price cancelled or expired.. No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right weighted average exercise price exercised. No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right weighted average exercise price issued. No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right weighted average exercise price outstanding. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|